American Society of Clinical Oncology 2014: Updates in breast and gastrointestinal cancers

被引：2

作者：

Dawood, Shaheenah ^{[1
]}

机构：

[1] Dubai Hosp, Dept Med Oncol, Dubai, U Arab Emirates

来源：

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2014年 / 35卷 / 02期

关键词：

Breast cancer; colon cancer; gastric cancer;

D O I：

10.4103/0971-5851.138997

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The last two decades have been very exciting in the realm of breast and GI oncology with a plethora of new information that has significantly impacted clinical practice. From the use of anti HER 2 agents in both the adjuvant and metastatic settings of breast cancer to the use of anti EGFR agents in the metastatic setting of colorectal cancer we have seen some significant advances in the treatment of these diseases. This year at ASCO 2014 data were presented that attempted to answer important clinical questions faced by a community oncologist in the clinic. This review focuses on important data presented for both breast and GI cancer.

引用

页码：176 / 180

页数：5

共 16 条

[1]

Arnold D, 2014, J CLIN ONCOL S, V32

[2]

Bruix J, 2014, J CLIN ONCOL S, V32

[3]

Dienstmann R, 2014, ASCO M, V32, P3511, DOI DOI 10.1200/jco.2014.32.15_suppl.3511

[4] RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of metastatic gastroesophageal junction and gastric adenocarcinoma (mGC) following disease progression on first-line platinum-and fluoropyrimidine-containing combination therapy-Efficacy analysis in Japanese and Western patients. [J].

Hironaka, Shuichi ;

Shimada, Yasuhiro ;

Sugimoto, Naotoshi ;

Komatsu, Yoshito ;

Nishina, Tomohiro ;

Yamaguchi, Kensei ;

Segawa, Yoshihiko ;

Omuro, Yasushi ;

Tamura, Takao ;

Doi, Toshihiko ;

Yukisawa, Seigo ;

Yasui, Hirofumi ;

Nagashima, Fumio ;

Gotoh, Masahiro ;

Esaki, Taito ;

Emig, Michael ;

Chandrawansa, Kumari ;

Muro, Kei ;

Wilke, Hansjochen ;

Ohtsu, Atsushi .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[5] Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE). [J].

Hong, Yong Sang ;

Nam, Byung-Ho ;

Kim, Kyu-Pyo ;

Lee, Jae-Lyun ;

Park, Joon Oh ;

Park, Young Suk ;

Kim, Sun Young ;

Kim, Tae-You ;

Kim, Jee Hyun ;

Ahn, Joong Bae ;

Jung, Kyung Hae ;

Kim, Tae Won .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[6] Adjuvant gemcitabine for high-risk breast cancer (BC) patients: Final survival results of the randomized phase III SUCCESS-A study. [J].

Janni, Wolfgang ;

Schneeweiss, Andreas ;

Haeberle, Lothar ;

Fasching, Peter A. ;

Sommer, Harald Leo ;

Rezai, Mandi ;

Hilfrich, Joern ;

Tesch, Hans ;

Heinrich, Georg ;

Forstbauer, Helmut ;

Fried, Thomas W. P. ;

Schochter, Fabienne ;

Albrecht, Susanne ;

Jaeger, Bernadette ;

Jueckstock, Julia Kathrin ;

Friese, Klaus ;

Lichtenegger, Werner ;

Beckmann, Matthias W. ;

Rack, Brigitte Kathrin .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[7] Mutation and copy number discordance in primary versus metastatic colorectal cancer (mCRC). [J].

Kopetz, Scott ;

Overman, Michael J. ;

Chen, Ken ;

Lucio-Eterovic, Agda Karina ;

Kee, Bryan K. ;

Fogelman, David R. ;

Dasari, Arvind ;

Pratap, Kanwal ;

Raghav, Singh ;

Sanchez, Eduardo Vilar ;

Phillips, Jonathan ;

Shureiqi, Imad ;

Garrett, Chris R. ;

Wolff, Robert A. ;

Patel, Keyur ;

Aldape, Kenneth D. ;

Luthra, Rajyalakshmi ;

Routbort, Mark ;

Maru, Dipen M. ;

Meric-Bernstam, Funda ;

Eng, Cathy .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[8] Prognostic associations of 250H vitamin D in NCIC CTG MA.21, a phase HI adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC). [J].

Lohmann, Ana Elisa ;

Chapman, Judy-Anne W. ;

Burnell, Margot J. ;

Levine, Mark Norman ;

Tsvetkova, Elena ;

Pritchard, Kathleen I. ;

Mon, Karen A. Gel ;

O'Brien, Patti ;

Han, Lei ;

Rugo, Hope S. ;

Albain, Kathy S. ;

Perez, Edith A. ;

Vandenberg, Theodore A. ;

Chalchal, Ho I. ;

Sawhney, Ravinder Pal Singh ;

Shepherd, Lois E. ;

Goodwin, Pamela Jean .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[9] German Adjuvant Intergroup Node Positive (GAIN) study: A phase III trial to compare IDD-ETC versus EC-TX in patients with node-positive primary breast cancer-Final efficacy analysis. [J].

Moebus, Volker Jochen ;

Von Minckwitz, Gunter ;

Jackisch, Christian ;

Lueck, Hans-Joachim ;

Schneeweiss, Andreas ;

Tesch, Hans ;

Elling, Dirk ;

Harbeck, Nadia ;

Conrad, Bettina ;

Fehm, Tanja ;

Huober, Jens Bodo ;

Mueller, Volkmar ;

Bauerreind, Ingo ;

Schmidt, Marcus ;

Loibl, Sibylle ;

Nekljudova, Valentina ;

Untch, Michael ;

Thomssen, Christoph .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[10]

Pagani O, 2014, J CLIN ONCOL S, V32

← 1 2 →